Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 999 publications
Cost-effectiveness of non-statin lipid-lowering therapies as an add-on to statins for achieving low-density lipoprotein cholesterol therapeutic targets in very high-risk patients in the Spanish setting.
Journal: Journal of medical economics
Published: October 20, 2025
Challenges in the Choice of Nonstatin Medications for Low-Density Lipoprotein-C Lowering for Cardiovascular Risk Reduction.
Journal: Journal of the American Heart Association
Published: October 09, 2025
Multiplex Apolipoprotein Panel Improves Cardiovascular Event Prediction and Cardiovascular Outcome by Identifying Patients Who Benefit From Targeted PCSK9 Inhibitor Therapy.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: September 25, 2025
Inclisiran (Leqvio) monotherapy for LDL-cholesterol reduction.
Journal: The Medical letter on drugs and therapeutics
Published: September 09, 2025
Effective and safe use of alirocumab in spinal and bulbar muscular atrophy with high cardiovascular risk: a case report.
Journal: European review for medical and pharmacological sciences
Published: September 04, 2025
Effect of PCSK9 Inhibition With Alirocumab in Patients With Probable Familial Hypercholesterolemia or Type III Hyperlipoproteinemia: Results From the ODYSSEY OUTCOMES Trial.
Journal: Journal of the American Heart Association
Published: August 23, 2025
Lipoprotein(a) identifies patients with acute coronary syndromes who derive cardiovascular benefit from alirocumab, particularly for limb events.
Journal: Journal of the American College of Cardiology
Published: July 27, 2025
Clinical Efficacy of Atorvastatin and PCSK9 Inhibitors in Patients With Borderline Coronary Lesions: An Intravascular Ultrasound Assessment.
Journal: Journal of cardiovascular pharmacology and therapeutics
Published: July 24, 2025
Legacy Effects of Transient Intensive Lipid-Lowering With Alirocumab on Plaque Stabilization.
Journal: Circulation journal : official journal of the Japanese Circulation Society
Published: July 21, 2025
Medical and Financial Consequences of Using PCSK9 Inhibitors for Managing Hypercholesterolemia in Saudi Arabia: A Historical Cohort Study.
Journal: Healthcare (Basel, Switzerland)
Published: July 08, 2025
Optimizing PCSK9 inhibitor therapy: Understanding and managing suboptimal LDL-C response in clinical practice.
Journal: European journal of internal medicine
Published: July 06, 2025
The Effects of Inclisiran on the Subclinical Prothrombotic and Platelet Activation Markers in Patients at High Cardiovascular Risk.
Journal: Journal of cardiovascular development and disease
Published: July 01, 2025
Last Updated: 10/31/2025